Proa Medical, Inc., has been granted patents in China and Russia for the company’s first product, the Brella Vaginal Retractor. Generally, the company is involved in development of pioneering and practical medical devices with respect to care-technology for women’s health. Earlier on June 9, 2015 Proa Medical was granted a United States patent covering the Brella Vaginal Retractor from the United States Patent and Trademark Office.

Applied BioCode announced on February 9th, 2016 the grant of US Patent 9255922 from United Stated Patent and Trademark Office. Briefly, the granted patent describes the material and method of a digital barcode, and the specialty of which being 1,000 times smaller than the conventional barcodes. The digital barcode is mainly employed for simultaneous identification of thousands of bacteria, viruses, pathogens, or biomarkers.

On 11th of February 2016, Integral Molecular, Inc. announced the issuance of two key patents in Europe and the U.S, respectively. Integral Molecular, Inc. is a leader in membrane protein antibody discovery and the issuance of patents, EP166038 and US9213027, has further strengthened the company's rapidly expanding patent portfolio for its Lipoparticle technology.

Two additional patents US 9,184,463 (Ohlsen et al) and US 9,112,215 (Cross et al) have been awarded to Neah Power Systems, Inc. by USPTO. It’s a proud moment for the company which is a budding leader in the field of fuel cell-based power solutions and rechargeable lithium battery storage solutions for various arenas of defense, commercial, and consumer applications.

Illumina, an American company announced on 7th January 2016 that it has filed two patent infringements lawsuits against five companies in Europe over their use of noninvasive prenatal tests. In the lawsuit, Illumina claims violation of its intellectual property protections. Illumina’s profile: The American company was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee with the headquarters located in San Diego, California.

It was on January 7th 2016, that Gen9, an established company involved in DNA synthesis and assembly technology announced the issuance of four innovative U.S. patents in the ending of 2015. The patents are related to gene synthesis and synthetic biology technologies. It is quite understandable that the awarded patents have further added feathers of success to Gen9’s already extensive intellectual property portfolio encompassing more than 100 patents and with many patents pending.

Pinnacle Spine Group received a patent entitled "Intervertebral Implants and Related Tools," which is third in the series casing the company's InFill fusion technology on 22nd December 2015. On an introductory note, Pinnacle Spine Group was established with the “goal of developing innovative medical devices, conceived in the operating room, for surgical procedures of the spine”.

Two United States Patent and Trademark Office (USPTO) patents have been granted to AlloSource on Dec. 29th 2015 for cartilage repair allografts. AlloSource is one of the principal providers of cartilage, cellular, bone, skin and soft-tissue allografts, which are importantly employed in surgical procedures and for wound care to advance the process of healing in patients.

A Canadian patent has been granted to Regenerative medicine company, Orthocell Limited for Canadian Patent Application No. 2685146 entitled “Tenocyte containing bioscaffolds and treatments using the same” and the announcement was made on 9th Dec. 2015, Perth, Australia. The patent granted covers the combination of bio-scaffolds and tenocytes, the cells that make up healthy tendons for tendon regeneration.

Scientists including Lanying Du, Ph.D.; Francesca Curreli, Ph.D.; Beth Shaz, M.D.; Christopher D. Hillyer, M.D.; Asim K. Debnath, Ph.D.; Sara Lustigman, Ph.D. from the New York Blood Center (NYBC) have been honored with several new patents in 2014 / 15 for numerous projects that are intended to preserve the U.S. blood supply and advance vaccine therapies ...